Original Article
Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction
Benefício a longo prazo do tratamento com inibidores da enzima de conversão da angiotensina ou antagonistas do recetor da angiotensina, após intervenção coronária percutânea bem-sucedida, no enfarte agudo do miocárdio sem elevação do segmento ST
Lido
7309
Vezesque se leu este artigo
2232
Total PDF
5077
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 39 | 7 | 46 |
| 2025 5 | 102 | 37 | 139 |
| 2025 4 | 66 | 36 | 102 |
| 2025 3 | 78 | 24 | 102 |
| 2025 2 | 57 | 20 | 77 |
| 2025 1 | 37 | 39 | 76 |
| 2024 12 | 39 | 24 | 63 |
| 2024 11 | 71 | 43 | 114 |
| 2024 10 | 46 | 36 | 82 |
| 2024 9 | 52 | 32 | 84 |
| 2024 8 | 47 | 26 | 73 |
| 2024 7 | 40 | 37 | 77 |
| 2024 6 | 37 | 21 | 58 |
| 2024 5 | 42 | 20 | 62 |
| 2024 4 | 63 | 34 | 97 |
| 2024 3 | 41 | 23 | 64 |
| 2024 2 | 35 | 25 | 60 |
| 2024 1 | 34 | 35 | 69 |
| 2023 12 | 40 | 29 | 69 |
| 2023 11 | 34 | 27 | 61 |
| 2023 10 | 18 | 21 | 39 |
| 2023 9 | 21 | 19 | 40 |
| 2023 8 | 31 | 19 | 50 |
| 2023 7 | 38 | 12 | 50 |
| 2023 6 | 33 | 14 | 47 |
| 2023 5 | 43 | 30 | 73 |
| 2023 4 | 35 | 3 | 38 |
| 2023 3 | 48 | 24 | 72 |
| 2023 2 | 44 | 20 | 64 |
| 2023 1 | 18 | 16 | 34 |
| 2022 12 | 52 | 19 | 71 |
| 2022 11 | 44 | 34 | 78 |
| 2022 10 | 61 | 27 | 88 |
| 2022 9 | 33 | 32 | 65 |
| 2022 8 | 40 | 29 | 69 |
| 2022 7 | 36 | 37 | 73 |
| 2022 6 | 29 | 39 | 68 |
| 2022 5 | 36 | 36 | 72 |
| 2022 4 | 49 | 38 | 87 |
| 2022 3 | 44 | 42 | 86 |
| 2022 2 | 29 | 27 | 56 |
| 2021 1 | 51 | 41 | 92 |
| 2021 12 | 33 | 38 | 71 |
| 2021 11 | 50 | 37 | 87 |
| 2021 10 | 52 | 50 | 102 |
| 2021 9 | 38 | 33 | 71 |
| 2021 8 | 41 | 39 | 80 |
| 2021 7 | 28 | 31 | 59 |
| 2021 6 | 47 | 26 | 73 |
| 2021 5 | 45 | 46 | 91 |
| 2021 4 | 82 | 32 | 114 |
| 2021 3 | 78 | 35 | 113 |
| 2021 2 | 83 | 16 | 99 |
| 2020 1 | 35 | 27 | 62 |
| 2020 12 | 55 | 22 | 77 |
| 2020 11 | 40 | 19 | 59 |
| 2020 10 | 24 | 17 | 41 |
| 2020 9 | 81 | 12 | 93 |
| 2020 8 | 22 | 11 | 33 |
| 2020 7 | 73 | 13 | 86 |
| 2020 6 | 53 | 18 | 71 |
| 2020 5 | 53 | 12 | 65 |
| 2020 4 | 62 | 11 | 73 |
| 2020 3 | 65 | 16 | 81 |
| 2020 2 | 135 | 16 | 151 |
| 2020 1 | 51 | 9 | 60 |
| 2019 12 | 46 | 13 | 59 |
| 2019 11 | 48 | 21 | 69 |
| 2019 10 | 43 | 10 | 53 |
| 2019 9 | 78 | 5 | 83 |
| 2019 8 | 44 | 11 | 55 |
| 2019 7 | 45 | 11 | 56 |
| 2019 6 | 33 | 28 | 61 |
| 2019 5 | 55 | 6 | 61 |
| 2019 4 | 36 | 11 | 47 |
| 2019 3 | 72 | 21 | 93 |
| 2019 2 | 84 | 12 | 96 |
| 2019 1 | 77 | 15 | 92 |
| 2018 12 | 73 | 14 | 87 |
| 2018 11 | 118 | 16 | 134 |
| 2018 10 | 293 | 21 | 314 |
| 2018 9 | 47 | 16 | 63 |
| 2018 8 | 30 | 14 | 44 |
| 2018 7 | 19 | 6 | 25 |
| 2018 6 | 37 | 8 | 45 |
| 2018 5 | 18 | 8 | 26 |
| 2018 4 | 41 | 3 | 44 |
| 2018 3 | 47 | 10 | 57 |
| 2018 2 | 21 | 2 | 23 |
| 2018 1 | 18 | 13 | 31 |
| 2017 12 | 39 | 5 | 44 |
| 2017 11 | 53 | 9 | 62 |
| 2017 10 | 33 | 12 | 45 |
| 2017 9 | 25 | 9 | 34 |
| 2017 8 | 50 | 15 | 65 |
| 2017 7 | 27 | 12 | 39 |
| 2017 6 | 28 | 9 | 37 |
| 2017 5 | 29 | 12 | 41 |
| 2017 4 | 25 | 4 | 29 |
| 2017 3 | 23 | 5 | 28 |
| 2017 2 | 37 | 8 | 45 |
| 2017 1 | 30 | 16 | 46 |
| 2016 12 | 90 | 66 | 156 |
| 2016 11 | 6 | 15 | 21 |
Mostrar tudo
